EC demanded from AstraZeneca to explain the reduction in vaccine supply

This was announced by the official representative of the EC Stefan De Keersmaker.

“European Health Commissioner Stella Kyriakidis has sent a letter to the company's management, demanding further clarification in connection with the company's announcement last week that it would cut vaccine supplies to the EU.

She stressed the need to fulfill the company's obligations under the contract with the EU, ”TASS quotes him.

He added that this issue will be discussed on January 25 at a meeting of the company's governing council and EU representatives.

In November, the European Commission signed six contracts for the purchase of potential vaccines against coronavirus from AstraZeneca, American companies Johnson & Johnson and Moderna, a joint drug of French Sanofi and British GlaxoSmithKlin (GSK), vaccine by the German pharmaceutical company BioNTech and the American concern Pfizer, and a drug by the German pharmaceutical company CureVac.

Earlier, Estonia, Latvia and Lithuania called on the EU to start distributing the AstraZeneca vaccine before its official approval by the European Medicines Agency.